Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions: Molecular Therapy Methods & Clinical Development

Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease

Frontiers Precision nutrition: Maintaining scientific integrity while realizing market potential

7 Developing and Delivering the Next Generation of Therapies, Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action

Sickle Cell Gene Therapy Will Test How US Pays for Million-Dollar Cures - Bloomberg

Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues - ScienceDirect

Gene and cell therapy - ScienceDirect

JPM, Free Full-Text

Bridging Gaps for Affordable Cell and Gene Therapies: Overcoming Financial and Systematic Obstacles

2021 Report to Congress: Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program by NICHQ - Issuu

Federal Register :: Medicare and Medicaid Programs; CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Medicare and Medicaid

Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe

Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues - ScienceDirect

Bridging Gaps for Affordable Cell and Gene Therapies: Overcoming Financial and Systematic Obstacles